52 results
8-K
CELU
Celularity Inc - Ordinary Shares
17 Jan 24
Entry into a Material Definitive Agreement
4:14pm
with Genting Innovation Pte Ltd as a prepayment towards the loan. The Second Amended Loan includes customary events of default.
Pursuant to the Second Amended
8-K
EX-10.5
CELU
Celularity Inc - Ordinary Shares
17 Jan 24
Entry into a Material Definitive Agreement
4:14pm
. and Genting Innovation Pte Ltd (as may be amended, restated, supplemented or otherwise modified from time to time) in connection with or related
8-K
EX-10.1
CELU
Celularity Inc - Ordinary Shares
17 Jan 24
Entry into a Material Definitive Agreement
4:14pm
and Restated Distribution and Manufacturing Agreement dated June 14, 2023 by and between the Company and Genting Innovation (as defined below … ) substantially in the form of Exhibit B attached hereto pursuant to which Genting Innovation was granted supply, distribution and manufacturing rights
8-K
EX-99.1
CELU
Celularity Inc - Ordinary Shares
7 Sep 23
Celularity Appoints Geoffrey Shiu Fei Ling, M.D., Ph.D. to its Board of Directors
4:21pm
Agency (DARPA) and as Assistant Director for Medical Innovation of the Science Division in President Obama’s White House Office of Science and Technology
8-K
EX-99.1
tmctbar21
31 May 23
THE NEXT EVOLUTION IN CELLULAR MEDICINE Investor Presentation June 2023
5:08pm
8-K
EX-99.1
93klza7u
10 Nov 22
Celularity Reports Third Quarter 2022 Financial Results and Provides Corporate Update
4:19pm
424B3
a9mvp lid
10 Aug 22
Prospectus supplement
12:00am
424B3
5e3rz0sw3ao gi
10 Aug 22
Prospectus supplement
12:00am
8-K
EX-99.1
wbuuacy243ljh95l
17 Jun 22
Other Events
4:57pm
424B3
khj3j419w
1 Jun 22
Prospectus supplement
4:06pm
424B3
q9ufj
16 May 22
Prospectus supplement
8:20pm